Clearside Biomedical, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
CLSD on Nasdaq
Location
900 North Point Parkway, Suite 200, Alpharetta, GA

Insiders trading volume in the past year

Clearside Biomedical, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradford T. Whitmore 10%+ Owner $9.24M +$600K +6.94% Feb 7, 2024
Clay Thorp Director $4.55M Jun 20, 2024
George M. Lasezkay CEO, Director $593K -$22.9K -3.71% Jan 18, 2024
Charles A. Deignan Chief Financial Officer $489K -$16.5K -3.27% Jan 18, 2024
Thomas Ciulla Chief Medical Officer $371K Jan 20, 2023
Anthony S. Gibney Director $130K +$130K +38706% Jun 20, 2024
Nancy J. Hutson Director $118K Jun 20, 2024
Ngai Hang Victor Chong Chief Medical Officer $100K +$109K Nov 1, 2024
William D. Humphries Director $64.8K Jun 20, 2024
Benjamin R. Yerxa Director $23.5K +$10.2K +77% Jun 20, 2024
Richard Croarkin Director Jun 20, 2024
Christy L. Shaffer Director Jun 20, 2024
Jeffrey L. Edwards Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Clearside Biomedical, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.